Key Highlights
● Shareholders of Dror Ortho-Design (OTC:DROR) approved a reverse split ratio ranging from 1-for-2 to 1-for-2,000 at a September 23, 2026 special meeting.
● The board can select the exact ratio and timing anytime before September 23, 2027, and must publicly announce it once chosen.
● The split proposal passed with over 707 million votes in favor versus about 1.45 million against, with no abstentions.
● The filing does not state a purpose for the split or disclose the company's current total shares outstanding.
Dror Ortho-Design, Inc. (OTC:DROR), a Delaware company in the dental equipment and supplies business, disclosed in a Form 8-K filed September 25, 2026 that shareholders approved giving the Board of Directors authority to execute a Reverse Stock Split at a ratio anywhere between 1-for-2 and 1-for-2,000. The vote took place at a special meeting held September 23, 2026.
A Wide Range Left to the Board
Rather than fixing a specific ratio, the proposal shareholders approved grants the board discretion to select the exact exchange ratio and timing of a reverse split, anywhere within the 1-for-2 to 1-for-2,000 range, at any point before the one-year anniversary of the Shareholder vote, that is, before September 23, 2027. The filing states that once the board settles on a specific ratio, the company is required to publicly announce it. As of this filing, no specific ratio has been selected or disclosed.
A range this wide is unusually broad; most reverse splits are announced with a single fixed ratio, such as 1-for-10 or 1-for-25. Granting the board discretion over such a large span gives Dror Ortho-Design flexibility to calibrate the ratio closer to the time of execution, based on the prevailing share price and market conditions, rather than committing to a fixed number many months in advance.
The Vote Itself
According to the filing, the reverse stock split proposal passed with 707,862,992.08 votes in favor and 1,451,900 votes against, with no abstentions recorded. A related adjournment proposal, which would have allowed the meeting to be postponed if needed to solicit additional votes, passed by a similar margin: 709,192,992.08 votes for versus 121,900 against, again with no abstentions. The filing reports the vote tallies in raw numbers rather than percentages.
What Wasn't Disclosed
The 8-K does not state an explicit purpose behind the reverse split authorization, for instance, whether the company is pursuing it to meet a listing standard on a national exchange, to reduce its outstanding share count ahead of a financing, or for another corporate reason. Dror Ortho-Design's stock is identified in the ticker reference as trading over the counter (OTC:DROR), and the filing does not indicate the company is currently listed on, or seeking to list on, Nasdaq or NYSE American, which would typically be the context for a bid-price-driven reverse split.
The filing also does not disclose the company's current total shares outstanding, meaning the effect of even the low end of the ratio range (1-for-2) versus the high end (1-for-2,000) on share count cannot be calculated from this document alone.
Business Background
Dror Ortho-Design is described in SEC classification data as operating in the dental equipment and supplies industry. The filing itself, focused on Item 5.07 shareholder voting results, does not provide further detail on the company's products, Revenue or recent operating history.
Item 5.07 filings are limited by design to reporting the outcomes of matters put to a shareholder vote, and companies routinely follow up such votes with a separate announcement once a board takes action on the authority granted. That means a later filing, rather than this one, would be the vehicle through which Dror Ortho-Design confirms an actual split ratio, an effective date, and the resulting number of shares outstanding once fractional-share cash payments and rounding are applied.
Wide-ranging authorizations of this kind are more common among smaller, thinly traded companies whose share prices can move significantly between a shareholder vote and a board's later action, since a ratio fixed months in advance can become mismatched to the stock's price by the time it is implemented.
The Board's Unused Discretion, Explained
Whether and when the board selects a specific ratio within the 1-for-2 to 1-for-2,000 range and publicly announces it remains to be seen. The September 23, 2027 deadline marks when the shareholder-granted authority to execute the split would expire if unused, and any subsequent disclosure explaining the Business rationale for the split, such as a listing application or capital-raising plan, would Fill in detail this filing leaves out.






Please wait processing your request...